Lumontad, Christian Jade O.
HRN: 18-43-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFTRIAXONE 1G (VIAL)
09/29/2022
10/06/2022
IV
1g
Q12
S/P OR-IM Nailing, Femur, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes